1)Bouros D, et al:Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 165:1581-1586, 2002
2)Gohr NS, et al:Interstitial lung disease in systemic sclerosis;A simple staging system. Am J Respir Crit Care Med 177:1248-1254, 2008
3)Yokoyama A, et al:Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology 11:164-168, 2006
4)Flaherty KR, et al:Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 168:543-548, 2003
5)Latsi PI, et al:Fibrotic idiopathic interstitial pneumonia;The prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 168:531-537, 2003
6)Schreiber BE, et al:Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests. Arthritis Rheum DOI 10.1002/art.30535, 2011
7)Tashkin DP, et al:Cyclophosphamide in scleroderma lung disease. N Engl J Med 355:1173-1174, 2006
8)Hoyles RK, et al:A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 54:3962-3970, 2006